Related Experiment Video
Updated: Dec 4, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Communicating personalized risk of diabetes and offering weight reduction program choice: Recruitment, participation,
Lisa Bailey-Davis1, G Craig Wood2, Adam Cook2
1Geisinger Obesity Institute, 100 N Academy Ave, MC 26-08, Danville, PA 17822 USA; Department of Population Health Sciences, Geisinger, 100 N Academy Ave, MC 44-00, Danville, PA 17822 USA.
Objective:
Low patient recruitment into diabetes prevention programs is a challenge. The primary aim of this study was to demonstrate that an increased recruitment rate can be achieved by communicating personalized risk of progression to type 2 diabetes, estimating risk reduction with weight loss, and offering program choice. Secondary aims included program participation rate, weight loss, and short-term decreased diabetes risk.
Methods:
In this single-arm study, persons with prediabetes from 3 primary care sites received a letter that communicated their personalized risk of progression to diabetes within 3-years, estimated risk reduction with 5, 10, 15 % weight loss, reported in pounds, and offered a choice of 5 free, 6-month, programs. A one-sided test was used to compare the recruitment rate against the maximum expected rate of (10 %).
Results:
Recruitment response rate was 25.3 % (81/328, 95 % CI=[20.0 %, 29.4 %]) which was significantly higher than expected (p < 0.0001). Overall, 65 % of participants completed >75 % of contacts. BMI, HbA1c, and diabetes risk (all p < 0.0001) improved at 6 months; BMI (p < 0.0001) and HbA1c (p < 0.05) improved at 12 months.
Conclusion:
Recruitment response rate was better than expected.
Practice Implications:
Communicating personalized risk and reduction estimates with a choice of programs resulted in favorable outcomes, sustained at 1-year.
Related Concept Videos
Role of Communication in the Nursing Process II: Planning and Implementation
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes: Symptoms, Diagnosis, and Complications

